Pascal Deschatelets Net Worth & Insider Trades

Pascal Deschatelets - Chief Scientific Officer, Apellis Pharmaceuticals, Inc

As of September 12, 2022

What is Pascal Deschatelets's Net Worth?

The current estimated net worth of Apellis Pharmaceuticals, Inc's Chief Scientific Officer, Pascal Deschatelets, is estimated to be about $65.97M . Pascal Deschatelets owns about 950,780 units of Apellis Pharmaceuticals, Inc common stock. In the last 4 years at Apellis Pharmaceuticals, Inc, Pascal Deschatelets has sold an estimated value of $10.33M worth.

What is Pascal Deschatelets's Past Insider Trading?

Pascal Deschatelets's largest purchase order was 234,411 units , worth over $501.64K on February 14, 2020. Pascal Deschatelets's largest sale order was 107,473 units , worth over $4.5M on February 14, 2020. In total, Pascal Deschatelets has made about 24 transactions over 4 years of their time at Apellis Pharmaceuticals, Inc. Pascal Deschatelets usually trades in February, with the busiest year in 2022. The most recent transaction was a sale order of 12,000 units , worth over $767.76K on September 12, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Pascal Deschatelets's Salary in 2020?

As Chief Scientific Officer of Apellis Pharmaceuticals, Inc, Pascal Deschatelets has a total base salary of $423,500 . Pascal Deschatelets received compensation valued at about $2,918,082 in 2020 after becoming Chief Scientific Officer. The vast majority of their compensation came in the form of a bonus of $239,062 , stock awards of $415,594 , option awards of $1,828,125 , and other compensation of $11,801 .

What is Pascal Deschatelets's' Mailing Address?

  • Mailing address is 6400 Westwind Way Suite A Crestwood KY 40014 KY

Apellis Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Cedric Francois, M.D., Ph.D. 2020 $618,769 $429,687 $1,523,844 $6,703,125 - $9,275,425
Cedric Francois, M.D., Ph.D. 2019 $560,019 $427,893 - $3,279,270 - $4,267,182
Cedric Francois, M.D., Ph.D. 2018 $550,000 $381,562 - $3,127,600 $15,378 $4,074,540
Timothy Sullivan 2020 $430,269 $244,688 $518,129 $2,279,063 $13,000 $3,485,149
Timothy Sullivan 2019 $386,423 $214,730 - $1,108,650 $9,500 $1,719,303
Timothy Sullivan 2018 $380,000 $190,000 - $279,250 $10,502 $859,752
Pascal Deschatelets, Ph.D. 2020 $423,500 $239,062 $415,594 $1,828,125 $11,801 $2,918,082
Pascal Deschatelets, Ph.D. 2019 $404,077 $252,608 - $1,108,650 $55,893 $1,821,228
Pascal Deschatelets, Ph.D. 2018 $400,000 $225,000 - $1,228,700 $8,657 $1,862,357
Nur Nicholson 2020 $138,462 $150,068 - $2,648,750 $84,874 $3,022,154
Adam Townsend 2020 $430,038 $217,500 $415,594 $1,828,125 $9,750 $2,901,007
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492422/000119312521126688/d887358ddef14a.htm

What are Apellis Pharmaceuticals, Inc's Past Insider Trades?

Apellis Pharmaceuticals, Inc's most recent insider trade came on September 16, 2022 by Alec MacHiels who sold 1,250 units worth $82.5K . In the last 5 years, insiders at Apellis Pharmaceuticals, Inc have sold an estimated value of $55.21M and bought an estimated value of $96.08M worth of shares. Insider trading is most common in February, with the busiest year in 2021. The most active traders at the company are Federico Grossi, CHIEF MEDICAL OFFICER,  Alec MacHiels, Director,  and Cedric Francois, Chief Executive Officer .

Apellis Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1